| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Maplight Therapeutics, Inc. (MPLT) have been net buyers, picking up 781,693 shares worth roughly $793K on balance. In the past 30 days, 2 insiders bought and 6 sold.
Leading the buying is Catalyst4, Inc. (10% Owner), now holding an estimated $271.8M in MPLT.
Not all activity pointed one way: 6 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), MPLT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 20.91M | $250.46M | +1.21M | |
| CEO | 1.25M | $14.93M | -147,639 | |
| CFO | 387.8K | $4.65M | - | |
| Dir | 358.2K | $4.29M | - | |
| Other | 298.9K | $3.58M | -47,158 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Hanson Kristopher | General Counsel | Sell | 13,917 | $30.13 | $419,263.08 | -2.0% | - | - | |
| May 11, 2026 | Kroeger Christopher A. | Chief Executive Officer | Sell | 68,491 | $28.47 | $1,949,634.12 | -0.5% | - | - | |
| May 7, 2026 | Foff Erin Pennock | Chief Medical Officer | Sell | 4,438 | $28.54 | $126,639.62 | -0.6% | -55.4% | - | |
| May 7, 2026 | Lillie James Woodruff | Chief Scientific Officer | Sell | 721 | $28.28 | $20,389.88 | -0.3% | -55.4% | - | |
| Feb 20, 2026 | Pavlov George64 | Director | Buy | 25,000 | $17.65 | $441,167.58 | +97.1% | +63.8% | - | |
| Feb 3, 2026 | Malenka Robert C. | Director | Sell | 7,040 | $18.02 | $126,860.78 | -1.0% | +79.4% | - | |
| Jan 30, 2026 | Malenka Robert C. | Director | Sell | 34,398 | $18.49 | $635,857.22 | -2.2% | +80.2% | - | |
| Oct 28, 2025 | Catalyst4, Inc. | 10% Owner | Buy | 5,441,176 | $17.00 | $92,499,992.00 | +38.2% | +7.3% | - | |
| Oct 28, 2025 | Novo Holdings A/s58 | 10% Owner | Buy | 952,941 | $17.00 | $16,199,997.00 | +34.9% | +7.3% | - |